Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Future Microbiology Année : 2017

Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice

Résumé

Development of protein vaccine to prevent congenital infection is a major public health priority. Our goal is the design of mucosal synthetic pathogen inducing protective immune responses against congenital toxoplasmosis. Mice were immunized intranasally, establishing pregnancy and challenging orally. Placental immune response, congenital infection, pup growth, parasitic load rates were studied. Pups born to vaccinated infected dams had significantly fewer brain cysts, no intraocular inflammation and normal growth. Protection was associated with a placental cellular Th1 response downregulated by IL-6 and correlated with persistence of vaccine for few hours in the nose before being totally eliminated. Our vaccine conferred high protection against congenital toxoplasmosis. These results provide support for future studies of other congenital vaccine.
Fichier principal
Vignette du fichier
2017_Ducournau_FutureMicrobiol_1.pdf (2.58 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01608412 , version 1 (26-05-2020)

Licence

Paternité - Partage selon les Conditions Initiales

Identifiants

Citer

Céline Ducournau, Thi Thanh Loi Nguyen, Rodolphe Carpentier, Isabelle Lantier, Stéphanie Germon, et al.. Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice. Future Microbiology, 2017, 12 (5), pp.393-405. ⟨10.2217/fmb-2016-0146⟩. ⟨hal-01608412⟩
194 Consultations
51 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More